Not yet recruiting
Clinical Trial of SEEG for Drug-resistant Epilepsy
NCT07923058· Beijing Pins Medical Co., Ltd· Source
Contact: Changqing Liu
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
NCT07778316· Phase 3· Amgen· Source
Recruiting
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT07209787· Phase 4· Beijing Chao Yang Hospital· Source
Contact: Chunxiang Ye
Recruiting
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07292714· Phase 2· Mabwell (Shanghai) Bioscience Co., Ltd.· Source
Contact: Yongchang Sun, Doctor
Recruiting
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
NCT06817265· Phase 3· Beletalent (Zhuhai) Pharmaceutical Co., Ltd· Source
Contact: Yong Tao
Enrolling by invitation
Comparative Study of Rotational Cryobiopsy Needle and Automated Biopsy Needle in Transthoracic Biopsy Diagnosing Peripheral Pulmonary Lesions
NCT07772479· Beijing Chao Yang Hospital· Source
Recruiting
Multicenter Study of SIS Patch in High-risk Colorectal Anastomosis
NCT07931300· Beijing Chao Yang Hospital· Source
Contact: Chunxiang Ye
Recruiting
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)
NCT04916197· Phase 4· Beijing Chao Yang Hospital· Source
Contact: Lina Yang
Active, not recruiting
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
NCT06208150· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Optimal Evaluation to Reduce Cardiovascular Imaging Testing
NCT05640752· Tianjin Chest Hospital· Source
Contact: Yahang Tan
Active, not recruiting
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05572515· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Daratumumab
NCT05438043· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
NCT05243797· Phase 3· European Myeloma Network B.V.· Source
Recruiting
China HeadAche DIsorders RegiStry
NCT05334927· Beijing Tiantan Hospital· Source
Contact: Yong Gang Wang, Doctor
Active, not recruiting
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
NCT04662255· Phase 3· Loxo Oncology, Inc.· Source
Recruiting
Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer
NCT04743102· Beijing Chao Yang Hospital· Source
Contact: Jiagang Han
Active, not recruiting
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
NCT04273945· Phase 3· Actelion· Source
Active, not recruiting
Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)
NCT03783351· Beijing Anzhen Hospital· Source
Recruiting
CCTA Improves Clinical Management of Stable Chest Pain
NCT04691037· Tianjin Chest Hospital· Source
Contact: Yahang Tan